These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 23664123

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
    Bosse KE, Charlton JL, Susick LL, Newman B, Eagle AL, Mathews TA, Perrine SA, Conti AC.
    J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
    [Abstract] [Full Text] [Related]

  • 24. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL, Sorg BA, Schenk JO.
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [Abstract] [Full Text] [Related]

  • 25. Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction.
    Itzhak Y, Ali SF.
    Ann N Y Acad Sci; 2002 Jun; 965():127-35. PubMed ID: 12105090
    [Abstract] [Full Text] [Related]

  • 26. Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA).
    Brennan K, Johnstone A, Fitzmaurice P, Lea R, Schenk S.
    Drug Alcohol Depend; 2007 May 11; 88(2-3):204-13. PubMed ID: 17125936
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Methamphetamine-induced locomotor changes are dependent on age, dose and genotype.
    Good RL, Radcliffe RA.
    Pharmacol Biochem Behav; 2011 Mar 11; 98(1):101-11. PubMed ID: 21163294
    [Abstract] [Full Text] [Related]

  • 32. Chronic treatment with curcumin enhances methamphetamine locomotor sensitization and cue-induced reinstatement of methamphetamine self-administration.
    Zhao C, Lou Z, Zimmer B, Yu Z, Li P, Ma B, Sun Y, Huang K, Zhou W, Liu Y.
    Pharmacol Biochem Behav; 2012 Oct 11; 102(4):555-61. PubMed ID: 22750063
    [Abstract] [Full Text] [Related]

  • 33. Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine.
    Bhatia KS, Szabo ST, Fowler JC, Wetsel WC, Lee TH.
    Behav Brain Res; 2011 Sep 30; 223(1):227-32. PubMed ID: 21571009
    [Abstract] [Full Text] [Related]

  • 34. Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine.
    Ito K, Abekawa T, Koyama T.
    Psychopharmacology (Berl); 2006 Aug 30; 187(3):293-302. PubMed ID: 16850286
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.
    Itzhak Y, Martin JL, Black MD, Ali SF.
    Neuropharmacology; 1998 Jun 30; 37(6):781-91. PubMed ID: 9707292
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.